APA

Ratanatharathorn V., Karanes C., Lum L. G., Uberti J., Dan M. E., de Planque M. M., Schultz K. R., Cronin S., Leisz M. C. & Mohamed A. (19920413). Allogeneic bone marrow transplantation in high-risk myeloid disorders using busulfan, cytosine arabinoside and cyclophosphamide (BAC). : Bone marrow transplantation.

Chicago

Ratanatharathorn V, Karanes C, Lum L G, Uberti J, Dan M E, de Planque M M, Schultz K R, Cronin S, Leisz M C and Mohamed A. 19920413. Allogeneic bone marrow transplantation in high-risk myeloid disorders using busulfan, cytosine arabinoside and cyclophosphamide (BAC). : Bone marrow transplantation.

Harvard

Ratanatharathorn V., Karanes C., Lum L. G., Uberti J., Dan M. E., de Planque M. M., Schultz K. R., Cronin S., Leisz M. C. and Mohamed A. (19920413). Allogeneic bone marrow transplantation in high-risk myeloid disorders using busulfan, cytosine arabinoside and cyclophosphamide (BAC). : Bone marrow transplantation.

MLA

Ratanatharathorn V, Karanes C, Lum L G, Uberti J, Dan M E, de Planque M M, Schultz K R, Cronin S, Leisz M C and Mohamed A. Allogeneic bone marrow transplantation in high-risk myeloid disorders using busulfan, cytosine arabinoside and cyclophosphamide (BAC). : Bone marrow transplantation. 19920413.